polyclonal avian immunoglobulin igy containing specific igy against e. coli f18ab and s. typhimurium
Biologicalexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 16, 2017 (NCT03058224)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- polyclonal avian immunoglobulin igy containing specific igy against e. coli f18ab and s. typhimurium
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03058224 | N/A | Feb 16, 2017 | CenTrial GmbH, IgNova GmbH, Klinar CRO, Pharmasolutions4U, SCOPE International AG |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CenTrial GmbH | For profit | 1 | 0 | 1 | 2017 |
| IgNova GmbH | For profit | 1 | 1 | 1 | 2017 |
| Klinar CRO | For profit | 1 | 0 | 1 | 2017 |
| Pharmasolutions4U | For profit | 1 | 0 | 1 | 2017 |
| SCOPE International AG | For profit | 1 | 0 | 1 | 2017 |
5 organizations
Page 1 / 1